Esophageal Cancer Research and Treatment

SEP 9, 2026 · JOURNAL ARTICLE

Gastric Mucosa Cancer Risk: The Operative Link on Gastritis Assessment Staging System

The Korean Journal of Helicobacter and Upper Gastrointestinal Research

A narrative review synthesizing evidence on gastric atrophy staging and risk stratification to inform clinical surveillance strategy and serological monitoring in individual patients.

SEP 7, 2026 · JOURNAL ARTICLE

Do not try this at home: patterns and outcomes of radiation dose de-escalation in p16-positive oropharyngeal carcinoma

Frontiers in Oncology

Large national cohort study with hard clinical outcome (overall survival) showing inferior outcomes with dose de-escalation, aligning with recent randomized evidence and supporting current standard-of-care dosing.

SEP 7, 2026 · JOURNAL ARTICLE

Surgical management of small bowel metastasis from esophageal squamous cell carcinoma: a case report and literature review

Frontiers in Surgery

A single case report with clinical narrative describing an unusual metastatic pattern; it raises mechanistic hypotheses and clinical management questions but provides no comparative data, control group, or generalizable evidence.

SEP 6, 2026 · JOURNAL ARTICLE

Prophylactic treatment of regional lymph drainage zones in stage T1–2N0M0 oral cavity cancer: a retrospective population-based analysis

South Russian Journal of Cancer

Rigorous population-based retrospective cohort study with multivariable adjustment comparing four treatment strategies in localized oral cavity cancer, demonstrating significantly improved survival with elective neck dissection versus omission or radiotherapy alone.

SEP 5, 2026 · JOURNAL ARTICLE

Comparative efficacy and safety of neoadjuvant and perioperative systemic therapies for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: a network meta analysis of randomized controlled trials

BMC Gastroenterology

Network meta-analysis of 36 RCTs with 8925 patients comparing defined treatment classes for resectable locally advanced gastric cancer, with consistent superiority of chemotherapy plus immunotherapy across survival and pathological endpoints, but limited by indirect comparisons and heterogeneous trial populations.

SEP 5, 2026 · JOURNAL ARTICLE

Efficacy and Safety of DVDMS ‐Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial

Cancer Science

Phase II trial with modest sample size showing acceptable safety profile and 40% response rate for dysphagia in advanced esophageal cancer, but requires larger confirmatory studies before clinical adoption.

SEP 4, 2026 · JOURNAL ARTICLE

The road ahead: understanding recurrence and prognostic factors in oral cavity cancer

Reports of Practical Oncology & Radiotherapy

Single-institution prospective cohort with uniform treatment identifying prognostic factors for disease-free survival in oral cavity cancer, but lacks a comparator group and generalizability is limited to one centre.

SEP 4, 2026 · JOURNAL ARTICLE

Associations of baseline [18F]FDG PET/CT metabolic parameters with the efficacy of neoadjuvant immunotherapy plus concurrent chemoradiotherapy in patients with locally advanced gastric adenocarcinoma: a post hoc analysis of the Neo-PLANET phase II trial

BMC Medical Imaging

Post hoc analysis of a phase II trial with small sample (n=29) and surrogate/exploratory endpoints; findings are hypothesis-generating and require validation in larger populations.